+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rubella Test"

From
2022-2026 Global Rubella Diagnostic Testing Market: US, Europe, Japan - Product Thumbnail Image

2022-2026 Global Rubella Diagnostic Testing Market: US, Europe, Japan

  • Report
  • April 2022
  • Japan, United States, ... Japan, United States, Europe, Global
From
2022-2026 Global Rubella Testing in 90 Countries - Product Thumbnail Image

2022-2026 Global Rubella Testing in 90 Countries

  • Report
  • December 2021
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

The Rubella Test is a type of infectious disease testing used to detect the presence of rubella antibodies in a person's blood. It is used to diagnose rubella infection, as well as to determine if a person has been vaccinated against the virus. The test is typically performed by a healthcare provider, such as a doctor or nurse, and results are usually available within a few days. The Rubella Test market is a subset of the larger infectious disease testing market, which is estimated to be worth billions of dollars. The market is driven by the need to diagnose and treat infectious diseases, as well as the increasing prevalence of rubella in certain parts of the world. Some companies in the Rubella Test market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more